Literature DB >> 30021841

Angiopoietin-like 4 promotes the intracellular cleavage of lipoprotein lipase by PCSK3/furin in adipocytes.

Wieneke Dijk1, Philip M M Ruppert1, Lynette J Oost1, Sander Kersten2.   

Abstract

Lipoprotein lipase (LPL) catalyzes the breakdown of circulating triglycerides in muscle and fat. LPL is inhibited by several proteins, including angiopoietin-like 4 (ANGPTL4), and may be cleaved by members of the proprotein convertase subtilisin/kexin (PCSK) family. Here, we aimed to investigate the cleavage of LPL in adipocytes by PCSKs and study the potential involvement of ANGPTL4. A substantial portion of LPL in mouse and human adipose tissue was cleaved into N- and C-terminal fragments. Treatment of different adipocytes with the PCSK inhibitor decanoyl-RVKR-chloromethyl ketone markedly decreased LPL cleavage, indicating that LPL is cleaved by PCSKs. Silencing of Pcsk3/furin significantly decreased LPL cleavage in cell culture medium and lysates of 3T3-L1 adipocytes. Remarkably, PCSK-mediated cleavage of LPL in adipocytes was diminished by Angptl4 silencing and was decreased in adipocytes and adipose tissue of Angptl4-/- mice. Differences in LPL cleavage between Angptl4-/- and WT mice were abrogated by treatment with decanoyl-RVKR-chloromethyl ketone. Induction of ANGPTL4 in adipose tissue during fasting enhanced PCSK-mediated LPL cleavage, concurrent with decreased LPL activity, in WT but not Angptl4-/- mice. In adipocytes, after removal of cell surface LPL by heparin, levels of N-terminal LPL were still markedly higher in WT compared with Angptl4-/- adipocytes, suggesting that stimulation of PCSK-mediated LPL cleavage by ANGPTL4 occurs intracellularly. Finally, treating adipocytes with insulin increased full-length LPL and decreased N-terminal LPL in an ANGPTL4-dependent manner. In conclusion, ANGPTL4 promotes PCSK-mediated intracellular cleavage of LPL in adipocytes, likely contributing to regulation of LPL in adipose tissue. Our data provide further support for an intracellular action of ANGPTL4 in adipocytes.
© 2018 Dijk et al.

Entities:  

Keywords:  ANGPTL4; PCSK; adipocyte; angiopoietin-like 4; furin; human; lipase; lipoprotein lipase; lipoprotein metabolism; triglycerides

Mesh:

Substances:

Year:  2018        PMID: 30021841      PMCID: PMC6130958          DOI: 10.1074/jbc.RA118.002426

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  Heparin-binding defective lipoprotein lipase is unstable and causes abnormalities in lipid delivery to tissues.

Authors:  E P Lutz; M Merkel; Y Kako; K Melford; H Radner; J L Breslow; A Bensadoun; I J Goldberg
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

2.  Proteolytic processing of angiopoietin-like protein 4 by proprotein convertases modulates its inhibitory effects on lipoprotein lipase activity.

Authors:  Xia Lei; Fujun Shi; Debapriya Basu; Afroza Huq; Sophie Routhier; Robert Day; Weijun Jin
Journal:  J Biol Chem       Date:  2011-03-12       Impact factor: 5.157

3.  Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis.

Authors:  Yan Wang; Fabiana Quagliarini; Viktoria Gusarova; Jesper Gromada; David M Valenzuela; Jonathan C Cohen; Helen H Hobbs
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

4.  Proprotein convertases [corrected] are responsible for proteolysis and inactivation of endothelial lipase.

Authors:  Weijun Jin; Ilia V Fuki; Nabil G Seidah; Suzanne Benjannet; Jane M Glick; Daniel J Rader
Journal:  J Biol Chem       Date:  2005-08-18       Impact factor: 5.157

5.  Short-chain fatty acids stimulate angiopoietin-like 4 synthesis in human colon adenocarcinoma cells by activating peroxisome proliferator-activated receptor γ.

Authors:  Sheril Alex; Katja Lange; Tom Amolo; Jeffrey S Grinstead; Anders K Haakonsson; Ewa Szalowska; Arjen Koppen; Karin Mudde; Daniëlle Haenen; Sa'ad Al-Lahham; Han Roelofsen; René Houtman; Bart van der Burg; Susanne Mandrup; Alexandre M J J Bonvin; Eric Kalkhoven; Michael Müller; Guido J Hooiveld; Sander Kersten
Journal:  Mol Cell Biol       Date:  2013-01-22       Impact factor: 4.272

6.  Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease.

Authors:  Frederick E Dewey; Viktoria Gusarova; Colm O'Dushlaine; Omri Gottesman; Jesus Trejos; Charleen Hunt; Cristopher V Van Hout; Lukas Habegger; David Buckler; Ka-Man V Lai; Joseph B Leader; Michael F Murray; Marylyn D Ritchie; H Lester Kirchner; David H Ledbetter; John Penn; Alexander Lopez; Ingrid B Borecki; John D Overton; Jeffrey G Reid; David J Carey; Andrew J Murphy; George D Yancopoulos; Aris Baras; Jesper Gromada; Alan R Shuldiner
Journal:  N Engl J Med       Date:  2016-03-02       Impact factor: 91.245

Review 7.  Physiological regulation of lipoprotein lipase.

Authors:  Sander Kersten
Journal:  Biochim Biophys Acta       Date:  2014-04-08

8.  The GPIHBP1-LPL complex is responsible for the margination of triglyceride-rich lipoproteins in capillaries.

Authors:  Chris N Goulbourne; Peter Gin; Angelica Tatar; Chika Nobumori; Andreas Hoenger; Haibo Jiang; Chris R M Grovenor; Oludotun Adeyo; Jeffrey D Esko; Ira J Goldberg; Karen Reue; Peter Tontonoz; André Bensadoun; Anne P Beigneux; Stephen G Young; Loren G Fong
Journal:  Cell Metab       Date:  2014-04-10       Impact factor: 27.287

9.  Angiopoietin-like 4 promotes intracellular degradation of lipoprotein lipase in adipocytes.

Authors:  Wieneke Dijk; Anne P Beigneux; Mikael Larsson; André Bensadoun; Stephen G Young; Sander Kersten
Journal:  J Lipid Res       Date:  2016-03-31       Impact factor: 5.922

10.  Linking nutritional regulation of Angptl4, Gpihbp1, and Lmf1 to lipoprotein lipase activity in rodent adipose tissue.

Authors:  Olessia Kroupa; Evelina Vorrsjö; Rinke Stienstra; Frits Mattijssen; Stefan K Nilsson; Valentina Sukonina; Sander Kersten; Gunilla Olivecrona; Thomas Olivecrona
Journal:  BMC Physiol       Date:  2012-11-23
View more
  21 in total

1.  The intrinsic instability of the hydrolase domain of lipoprotein lipase facilitates its inactivation by ANGPTL4-catalyzed unfolding.

Authors:  Katrine Z Leth-Espensen; Kristian K Kristensen; Anni Kumari; Anne-Marie L Winther; Stephen G Young; Thomas J D Jørgensen; Michael Ploug
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-23       Impact factor: 11.205

Review 2.  ANGPTL4 in Metabolic and Cardiovascular Disease.

Authors:  Binod Aryal; Nathan L Price; Yajaira Suarez; Carlos Fernández-Hernando
Journal:  Trends Mol Med       Date:  2019-06-21       Impact factor: 11.951

3.  Coexpression of novel furin-resistant LPL variants with lipase maturation factor 1 enhances LPL secretion and activity.

Authors:  Ming Jing Wu; Anna Wolska; Benjamin S Roberts; Ellis M Pearson; Aspen R Gutgsell; Alan T Remaley; Saskia B Neher
Journal:  J Lipid Res       Date:  2018-10-14       Impact factor: 5.922

4.  Angiopoietin-like proteins as therapeutic targets for cardiovascular disease: focus on lipid disorders.

Authors:  Marco Bruno Morelli; Christopher Chavez; Gaetano Santulli
Journal:  Expert Opin Ther Targets       Date:  2020-01-15       Impact factor: 6.902

5.  Characterization of ANGPTL4 function in macrophages and adipocytes using Angptl4-knockout and Angptl4-hypomorphic mice.

Authors:  Antwi-Boasiako Oteng; Philip M M Ruppert; Lily Boutens; Wieneke Dijk; Xanthe A M H van Dierendonck; Gunilla Olivecrona; Rinke Stienstra; Sander Kersten
Journal:  J Lipid Res       Date:  2019-08-13       Impact factor: 5.922

6.  Screening of non-alcoholic steatohepatitis (NASH)-related datasets and identification of NASH-related genes.

Authors:  Ming-Jiang Liu; Hu Jin; Yu-Bing Chen; Jing-Jing Yu; Zhen-Ya Guo; Song-Qing He; Yong-Lian Zeng
Journal:  Int J Clin Exp Pathol       Date:  2021-05-15

7.  On the mechanism of angiopoietin-like protein 8 for control of lipoprotein lipase activity.

Authors:  Oleg Kovrov; Kristian Kølby Kristensen; Erika Larsson; Michael Ploug; Gunilla Olivecrona
Journal:  J Lipid Res       Date:  2019-01-27       Impact factor: 5.922

Review 8.  Lipoprotein Lipase and Its Regulators: An Unfolding Story.

Authors:  Shuangcheng Alivia Wu; Sander Kersten; Ling Qi
Journal:  Trends Endocrinol Metab       Date:  2020-12-01       Impact factor: 12.015

9.  Novel Adipose Tissue Targets to Prevent and Treat Atherosclerosis.

Authors:  Ludger Scheja; Joerg Heeren
Journal:  Handb Exp Pharmacol       Date:  2022

Review 10.  Research Progress on the Involvement of ANGPTL4 and Loss-of-Function Variants in Lipid Metabolism and Coronary Heart Disease: Is the "Prime Time" of ANGPTL4-Targeted Therapy for Coronary Heart Disease Approaching?

Authors:  Jingmin Yang; Xiao Li; Danyan Xu
Journal:  Cardiovasc Drugs Ther       Date:  2021-06       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.